Orsini Partners with Immedica Pharma to Launch Revolutionary Treatment for Rare Disease Orsini has been chosen as the exclusive specialty pharmacy partner for Immedica Pharma's LOARGYS, focusing on rare diseases and innovative therapies.

Orsini Partners with Immedica Pharma to Launch Revolutionary Treatment for Rare Disease #United_States #Elk_Grove_Village #Orsini #Loargys #Immedica

FDA Grants Accelerated Approval for Loargys® in Treating Hyperargininemia Immedica Pharma announces FDA's accelerated approval for Loargys®, designed for patients 2 years and older with Arginase 1 Deficiency, addressing a critical need in metabolic disease treatment.

FDA Grants Accelerated Approval for Loargys® in Treating Hyperargininemia #United_States #Chicago #Loargys #Arginase_1_Deficiency #Immedica_Pharma